For oral use. Tablets should be swallowed with water, preferably on an empty stomach (one hour before or two hours after food or fruit juice).

Bilastine selectively antagonizes peripheral H1 histamine receptors, thereby preventing the effects of histamine such as itching, swelling, and vasodilation.

• •Hypersensitivity to the active substance bilastine or to any of the excipients.

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

In case of overdose, symptomatic and supportive treatment should be initiated. There is no specific antidote for bilastine.

There are limited data on the use of bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects. As a precautionary measure, it is preferable to avoid the use of bilastine during pregnancy. It is unknown whether bilastine is excreted in human milk. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from bilastine therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.